This site is intended for health professionals only

Trial backs Cycloset safety profile

teaser

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

A significant reduction in the risk of diabetic cardiovascular complications has been noted in subjects with type 2 diabetes treated with Cycloset






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x